Literature DB >> 21684788

Large contiguous gene deletions in Sjögren-Larsson syndrome.

Holly Engelstad1, Gael Carney, Dana S'aulis, Janae Rise, Warren G Sanger, M Katharine Rudd, Gabriele Richard, Christopher W Carr, Omar A Abdul-Rahman, William B Rizzo.   

Abstract

Sjögren-Larsson syndrome (SLS) is an autosomal recessive disorder characterized by ichthyosis, mental retardation, spasticity and mutations in the ALDH3A2 gene for fatty aldehyde dehydrogenase, an enzyme that catalyzes the oxidation of fatty aldehyde to fatty acid. More than 70 mutations have been identified in SLS patients, including small deletions or insertions, missense mutations, splicing defects and complex nucleotide changes. We now describe 2 SLS patients whose disease is caused by large contiguous gene deletions of the ALDH3A2 locus on 17p11.2. The deletions were defined using long distance inverse PCR and microarray-based comparative genomic hybridization. A 24-year-old SLS female was homozygous for a 352-kb deletion involving ALDH3A2 and 4 contiguous genes including ALDH3A1, which codes for the major soluble protein in cornea. Although lacking corneal disease, she showed severe symptoms of SLS with uncommon deterioration in oral motor function and loss of ambulation. The other 19-month-old female patient was a compound heterozygote for a 1.44-Mb contiguous gene deletion and a missense mutation (c.407C>T, P136L) in ALDH3A2. These studies suggest that large gene deletions may account for up to 5% of the mutant alleles in SLS. Geneticists should consider the possibility of compound heterozygosity for large deletions in patients with SLS and other inborn errors of metabolism, which has implications for carrier testing and prenatal diagnosis. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684788      PMCID: PMC3196763          DOI: 10.1016/j.ymgme.2011.05.015

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  49 in total

1.  Defective inactivation of leukotriene B4 in patients with Sjögren-Larsson syndrome.

Authors:  M A Willemsen; J G de Jong; P H van Domburg; J J Rotteveel; R J Wanders; E Mayatepek
Journal:  J Pediatr       Date:  2000-02       Impact factor: 4.406

2.  Large de novo deletion in chromosome 12 affecting the PAH, IGF1, ASCL1, and TRA1 genes.

Authors:  J Mallolas; M A Vilaseca; C Pavia; N Lambruschini; F J Cambra; J Campistol; D Gómez; A Carrió; X Estivill; M Milà
Journal:  J Mol Med (Berl)       Date:  2001       Impact factor: 4.599

3.  Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells.

Authors:  A J Townsend; S Leone-Kabler; R L Haynes; Y Wu; L Szweda; K D Bunting
Journal:  Chem Biol Interact       Date:  2001-01-30       Impact factor: 5.192

4.  Corneal and stomach expression of aldehyde dehydrogenases: from fish to mammals.

Authors:  A Pappa; N A Sophos; V Vasiliou
Journal:  Chem Biol Interact       Date:  2001-01-30       Impact factor: 5.192

5.  RNA-based mutation screening in German families with Sjögren-Larsson syndrome.

Authors:  C Kraus; C Braun-Quentin; W G Ballhausen; R A Pfeiffer
Journal:  Eur J Hum Genet       Date:  2000-04       Impact factor: 4.246

6.  The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.

Authors:  W B Rizzo; G Carney; Z Lin
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

7.  Mouse ULK2, a novel member of the UNC-51-like protein kinases: unique features of functional domains.

Authors:  J Yan; H Kuroyanagi; T Tomemori; N Okazaki; K Asato; Y Matsuda; Y Suzuki; Y Ohshima; S Mitani; Y Masuho; T Shirasawa; M Muramatsu
Journal:  Oncogene       Date:  1999-10-21       Impact factor: 9.867

8.  The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion.

Authors:  J W Touchman; Y Anikster; N L Dietrich; V V Maduro; G McDowell; V Shotelersuk; G G Bouffard; S M Beckstrom-Sternberg; W A Gahl; E D Green
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

9.  Sjögren-Larsson syndrome: accumulation of free fatty alcohols in cultured fibroblasts and plasma.

Authors:  W B Rizzo; D A Craft
Journal:  J Lipid Res       Date:  2000-07       Impact factor: 5.922

10.  Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.

Authors:  Henriette E Meyer zu Schwabedissen; Celine Verstuyft; Heyo K Kroemer; Laurent Becquemont; Richard B Kim
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-06
View more
  10 in total

1.  Phenotypic and mutational spectrum of thirty-five patients with Sjögren-Larsson syndrome: identification of eleven novel ALDH3A2 mutations and founder effects.

Authors:  Mohamed S Abdel-Hamid; Mahmoud Y Issa; Hasnaa M Elbendary; Sherif F Abdel-Ghafar; Karima Rafaat; Heba Hosny; Marian Girgis; Ghada M H Abdel-Salam; Maha S Zaki
Journal:  J Hum Genet       Date:  2019-07-05       Impact factor: 3.172

2.  Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes.

Authors:  Kathleen Davis; Kenton R Holden; Dana S'Aulis; Claudia Amador; M Gisele Matheus; William B Rizzo
Journal:  J Child Neurol       Date:  2012-10-03       Impact factor: 1.987

3.  Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

Authors:  William B Rizzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-10       Impact factor: 0.694

4.  Chronic granulomatous disease, the McLeod phenotype and the contiguous gene deletion syndrome-a review.

Authors:  Casey E Watkins; John Litchfield; Eunkyung Song; Gayatri B Jaishankar; Niva Misra; Nikhil Holla; Michelle Duffourc; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2011-11-23

5.  A gatekeeper helix determines the substrate specificity of Sjögren-Larsson Syndrome enzyme fatty aldehyde dehydrogenase.

Authors:  Markus A Keller; Ulrich Zander; Julian E Fuchs; Christoph Kreutz; Katrin Watschinger; Thomas Mueller; Georg Golderer; Klaus R Liedl; Markus Ralser; Bernhard Kräutler; Ernst R Werner; Jose A Marquez
Journal:  Nat Commun       Date:  2014-07-22       Impact factor: 14.919

6.  Genotype and phenotype variability in Sjögren-Larsson syndrome.

Authors:  Maximilian Weustenfeld; Reiner Eidelpes; Matthias Schmuth; William B Rizzo; Johannes Zschocke; Markus A Keller
Journal:  Hum Mutat       Date:  2018-11-26       Impact factor: 4.878

Review 7.  Sjogren-Larsson Syndrome: Mechanisms and Management.

Authors:  Parayil Sankaran Bindu
Journal:  Appl Clin Genet       Date:  2020-01-07

8.  A Neurodegenerative Phenotype Associated With Sjögren-Larsson Syndrome.

Authors:  Simone Warrack; Terri Love; William B Rizzo
Journal:  J Child Neurol       Date:  2021-07-28       Impact factor: 1.987

9.  Identification of a novel deletion within ALDH3A2 gene in an Iranian Family with Sjögren-Larsson Syndrome.

Authors:  Maryam Taghdiri; Atie Kashef; Majid Fardaei; Mohammad Miryounesi
Journal:  Clin Case Rep       Date:  2017-11-22

10.  Sjogren-Larsson Syndrome: A case series of five members from an extended family with a novel mutation.

Authors:  Kamel T Abidi; Naglaa M Kamal; Ayman A Bakkar A; Maram Alotaibi; Haifa Asseri; Kawthar A Bokari
Journal:  Mol Genet Genomic Med       Date:  2020-09-15       Impact factor: 2.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.